Advanced Wound Care Global, our vehicle for bringing advanced wound care to areas of the world where the need and opportunity are greatest, was recently invited by Asian Hospital & Healthcare Management to share our thoughts on the potential for advanced wound care in Asia. Here is a brief excerpt from the intro: Asia has … Read More
Yesterday (29 Jul 2021), Bioventus and Misonix jointly announced an M&A. This deal is particularly significant in the advanced wound care (AWC) space for three reasons: The combined entity will be a “new” relatively large advanced wound care player (though similar to Misonix pre-deal, not necessarily with AWC as its sole focus). This is also … Read More
What We’ve Been up to in 2018 Q3 – Q4 and What It Means for the Global Wound Care Business Outlook A tour around the wound care world The past few months of 2018 have been quite packed and exciting for us at Diligence Wound Care Global. We wanted to share some of what we’ve … Read More
There has just been another significant wound care acquisition. French MNC Urgo Medical just announced the M&A of Texas-based SteadMed Medical. The resulting entity will be known as Urgo Medical North America. If you’re an advanced wound care stakeholder inside North America, you may be wondering, “Who is Urgo Medical?” If you’re an advanced wound … Read More
What happened? Today (2018.07.02), Mölnlycke Health Care announced its acquisition of SastoMed GmbH. Mölnlycke is of course known in the industry as a top global wound care (also wound prevention and surgical) product brand, particularly in Europe and the United States. SastoMed, a much smaller German firm, was a subsidiary of SanderStrothmann GmbH, a company which assesses, formulates, … Read More
![Wound Care in Malaysia and The Emerging Markets: Interview w/ Dr. Mogan Naidu (2 of 2) [Video]](http://cdn-5d8acb16f911c90950a62254.closte.com/wp-content/uploads/2018/05/24058772_2060153857552739_6783312044116283465_n-Edited-1.jpg "Wound Care in Malaysia and The Emerging Markets: Interview w/ Dr. Mogan Naidu (2 of 2) [Video]")
Back for Part 2… Wound care executives, investors, and specialists from all over the world enjoyed Part 1 of our visit with Dr. Mogan Naidu of MediAsia Advance Wound Care & Tissue Repair Center in Penang, in northern Malaysia. I have especially enjoyed witnessing an increased number of our colleagues and clients actively commenting and … Read More
EWMA 2018 (9-11 May) has just come to a close in beautiful Krakow, Poland. This annual global wound care conference is wonderful, bridging scientific, clinical, and industry stakeholders from around the world (most other annual wound conferences tend to draw from relatively regional audiences). Here are four key takeaways: 1. Less influence from reimbursement … Read More
![Wound Care in Malaysia and The Emerging Markets: Interview w/ Dr. Mogan Naidu (1 of 2) [Video]](http://cdn-5d8acb16f911c90950a62254.closte.com/wp-content/uploads/2018/04/IMG-20170815-WA0015.jpg "Wound Care in Malaysia and The Emerging Markets: Interview w/ Dr. Mogan Naidu (1 of 2) [Video]")
Do you feel confident in your command of global wound care? This video may cause you to reconsider… Much of our time at Diligence Wound Care Global is spent with wound care product and services CEOs, CMOs, CCOs, VPs, directors, and managers for global strategy, busdev, marketing, finance, R&D, and other functions related to commercial … Read More
Demographic and economic trends, combined with the sheer magnitude of the unmet needs in the emerging markets represents the largest untapped opportunity for advanced wound care products and services globally. Introduction As the business of advanced wound care in North America and Western Europe has boomed for the past two decades, most major wound care … Read More
The following is an excerpt from the original article, published in MedTech Intelligence on 3 Apr 2017: The attractive opportunities for medtech product firms to drive growth in the emerging and frontier markets are well-known: Rising disposable incomes and an expanding middle class, aging populations, and chronic disease prevalence (diabetes, cancer, obesity, hypertension, etc.), … Read More